tiprankstipranks
Trending News
More News >
ReposiTrak (TRAK)
NYSE:TRAK
Advertisement

ReposiTrak (TRAK) AI Stock Analysis

Compare
138 Followers

Top Page

TRAK

ReposiTrak

(NYSE:TRAK)

Select Model
Select Model
Select Model
Outperform 70 (OpenAI - 4o)
Rating:70Outperform
Price Target:
$14.50
▲(5.84% Upside)
ReposiTrak's overall stock score reflects strong financial performance and a positive earnings call, indicating robust profitability and strategic growth initiatives. However, technical analysis shows bearish momentum, and the high P/E ratio suggests potential overvaluation. Despite these concerns, the company's strong cash position and efficient operations support a favorable outlook.
Positive Factors
Revenue Growth
The 10% revenue growth indicates strong demand for ReposiTrak's solutions, suggesting effective market penetration and potential for sustained expansion.
Strong Cash Position
A robust cash position with no bank debt enhances financial flexibility, allowing ReposiTrak to invest in growth opportunities and weather economic uncertainties.
Efficiency Metrics
High revenue per employee indicates operational efficiency and effective resource utilization, contributing to sustained profitability and competitive advantage.
Negative Factors
Reduced Cash from Operations
The decline in cash from operations could indicate challenges in converting revenue into cash, potentially impacting liquidity and investment capacity.
Increased Operating Expenses
Rising operating expenses, particularly SG&A costs, may pressure margins if not offset by revenue growth, affecting long-term profitability.
Higher Effective Tax Rate
An increased tax rate could reduce net income, impacting cash flow and limiting funds available for reinvestment or shareholder returns.

ReposiTrak (TRAK) vs. SPDR S&P 500 ETF (SPY)

ReposiTrak Business Overview & Revenue Model

Company DescriptionReposiTrak, Inc. is a leading provider of supply chain and regulatory compliance solutions, primarily serving the retail and food sectors. The company focuses on enhancing product traceability, ensuring food safety, and streamlining supply chain operations through its innovative technology platform. ReposiTrak offers a suite of services including product compliance management, supplier risk assessment, and inventory management, catering to a diverse clientele that includes retailers, manufacturers, and distributors.
How the Company Makes MoneyReposiTrak generates revenue through a subscription-based model, where clients pay for access to its software platform and services. Key revenue streams include annual subscriptions for compliance and traceability solutions, transaction fees from the processing of product data, and consulting services aimed at helping businesses optimize their supply chain processes. Additionally, partnerships with major retailers and food industry stakeholders enhance revenue opportunities through shared compliance initiatives and data analytics services, allowing ReposiTrak to expand its market reach and strengthen its service offerings.

ReposiTrak Earnings Call Summary

Earnings Call Date:Nov 13, 2025
(Q1-2026)
|
% Change Since: |
Next Earnings Date:Feb 16, 2026
Earnings Call Sentiment Positive
The earnings call presented a generally positive outlook with significant revenue growth, increased profitability, and strong cash management. However, challenges such as reduced cash from operations, increased operating expenses, higher taxes, and data integrity issues were noted. Despite these challenges, the company's strategic initiatives and market positioning suggest a strong future potential.
Q1-2026 Updates
Positive Updates
Revenue Growth
First fiscal quarter revenue increased 10% from $5.4 million to $6 million.
Profitability Increase
Income from operations was up 28% to $1.9 million versus $1.5 million. GAAP net income increased 13% to $1.8 million from $1.7 million.
Efficiency Metrics
Revenue per employee was $356,000 on an annualized basis, twice the 2024 software industry average of $175,000 per employee.
Strong Cash Position
Total cash increased to $28.8 million with the company maintaining 0 bank debt.
Dividend and Share Buyback
Since inception, the company has redeemed approximately 572,000 shares of preferred stock and paid out over $5.7 million in cash dividends to shareholders.
Traceability Network Growth
ReposiTrak Traceability Network established as a dominant player, with significant leverage in traceability and food safety.
Negative Updates
Reduced Cash from Operations
Cash from operations was $1.5 million, down from $1.9 million in the year-ago quarter due to the conversion of deferred revenue to booked revenue.
Increased Operating Expenses
Total operating expenses for the quarter increased 3%, with SG&A costs up 6% due to higher payroll and benefit costs.
Higher Effective Tax Rate
The company is at the end of its benefit period from net operating losses, resulting in an expected higher tax rate moving forward.
Error Rate in Data
Initial data received from supply chain participants had a 70% error rate before ReposiTrak's correction processes.
Impact of Government Shutdown
The company noted some level of industry impact due to the government shutdown and related issues such as SNAP funding.
Company Guidance
During ReposiTrak's Fiscal First Quarter 2026 Earnings Call, the company provided optimistic guidance centered around robust growth metrics and financial stability. They reported a 10% increase in revenue, climbing from $5.4 million to $6 million, while operating expenses grew by only 3%, indicating efficient cost management. The company achieved a 28% rise in income from operations, reaching $1.9 million, and a 13% increase in GAAP net income to $1.8 million. With a focus on maintaining a lean operation, ReposiTrak generated $356,000 of revenue per employee, double the industry average. They also highlighted a strong balance sheet with $28.8 million in cash and no bank debt. Looking ahead, ReposiTrak aims to continue its strategy of growing annual recurring revenue by 10% to 20%, enhancing profitability, and pursuing strategic initiatives like software modernization to support continued expansion in all business lines. The company remains committed to returning 50% of annual free cash flow to shareholders through dividends and buybacks, and they've set a goal to redeem all remaining preferred shares by December 2026.

ReposiTrak Financial Statement Overview

Summary
ReposiTrak exhibits strong financial health with robust profitability, low leverage, and efficient cash flow management. The company is well-positioned for continued growth in the software application industry, supported by its high margins and stable financial structure. While free cash flow growth has seen a slight decline, overall financial performance remains strong, indicating a well-managed and financially sound company.
Income Statement
85
Very Positive
ReposiTrak demonstrates strong profitability with a high gross profit margin of 83.7% and a solid net profit margin of 30.9% in the TTM. Revenue growth is positive, albeit modest at 2.3% TTM, indicating steady expansion. The company maintains a healthy EBIT margin, although the TTM figure is not available, historical data shows consistent performance. Overall, the income statement reflects robust profitability and stable growth.
Balance Sheet
80
Positive
The balance sheet is strong with a low debt-to-equity ratio of 0.01, indicating minimal leverage and financial risk. Return on equity is healthy at 14.5% TTM, showcasing efficient use of equity capital. The equity ratio stands at 90.2%, reflecting a solid capital structure with a high proportion of equity financing. Overall, the balance sheet is stable with low leverage and effective equity utilization.
Cash Flow
75
Positive
Cash flow analysis shows a slight decline in free cash flow growth at -4.1% TTM, but the company maintains a strong operating cash flow to net income ratio of 1.52, indicating good cash generation relative to earnings. The free cash flow to net income ratio is nearly 1, suggesting efficient conversion of earnings to cash. Despite the decline in free cash flow growth, cash flow metrics remain solid overall.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue23.14M22.61M20.45M19.10M18.05M21.01M
Gross Profit19.46M18.92M17.04M15.79M14.86M13.10M
EBITDA8.70M8.95M7.61M7.11M5.38M5.41M
Net Income7.13M6.98M5.96M5.59M4.00M4.12M
Balance Sheet
Total Assets55.61M55.33M51.60M50.58M49.32M55.05M
Cash, Cash Equivalents and Short-Term Investments28.79M28.57M25.15M23.99M21.46M24.07M
Total Debt457.30K509.97K545.10K747.11K2.97M6.70M
Total Liabilities5.44M5.81M4.74M4.70M6.42M9.91M
Stockholders Equity50.17M49.52M46.85M45.88M42.90M45.14M
Cash Flow
Free Cash Flow8.06M8.40M6.89M7.96M6.05M5.08M
Operating Cash Flow8.09M8.42M6.96M8.86M6.10M5.40M
Investing Cash Flow-54.28K169.00-100.71K-903.19K1.32M-318.87K
Financing Cash Flow-5.03M-5.01M-5.70M-5.43M-10.03M-1.36M

ReposiTrak Technical Analysis

Technical Analysis Sentiment
Negative
Last Price13.70
Price Trends
50DMA
15.38
Negative
100DMA
16.35
Negative
200DMA
18.48
Negative
Market Momentum
MACD
-0.40
Positive
RSI
33.30
Neutral
STOCH
14.62
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TRAK, the sentiment is Negative. The current price of 13.7 is below the 20-day moving average (MA) of 14.80, below the 50-day MA of 15.38, and below the 200-day MA of 18.48, indicating a bearish trend. The MACD of -0.40 indicates Positive momentum. The RSI at 33.30 is Neutral, neither overbought nor oversold. The STOCH value of 14.62 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TRAK.

ReposiTrak Risk Analysis

ReposiTrak disclosed 26 risk factors in its most recent earnings report. ReposiTrak reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

ReposiTrak Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
$255.12M38.6914.60%0.54%11.05%18.55%
66
Neutral
$264.32M1.5813.13%-19.17%308.81%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
57
Neutral
$606.12M-28.65%16.40%22.80%
54
Neutral
$230.02M-20.20%-6.23%28.57%
53
Neutral
$274.34M-25.48%-24.30%-181.62%
48
Neutral
$256.48M-4.88%0.25%92.10%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TRAK
ReposiTrak
13.70
-8.81
-39.14%
EGHT
8X8
1.90
-1.28
-40.25%
MKTW
MarketWise
16.49
7.41
81.61%
FRGE
Forge Global Holdings
44.36
28.16
173.83%
ONTF
ON24
5.44
-1.17
-17.70%
SMRT
SmartRent
1.45
-0.17
-10.49%

ReposiTrak Corporate Events

Shareholder Meetings
ReposiTrak Holds Annual Stockholders Meeting
Neutral
Nov 20, 2025

On November 19, 2025, ReposiTrak, Inc. held its Annual Meeting of Stockholders where several key proposals were voted on. The election of directors resulted in the re-election of all nominees, and stockholders approved the executive compensation on a non-binding advisory basis. Additionally, it was decided that the advisory vote on executive compensation will occur every three years, and Haynie & Company was ratified as the independent auditor for the fiscal year ending June 30, 2026.

The most recent analyst rating on (TRAK) stock is a Buy with a $16.50 price target. To see the full list of analyst forecasts on ReposiTrak stock, see the TRAK Stock Forecast page.

Business Operations and StrategyDividendsFinancial Disclosures
ReposiTrak Reports Strong Q1 Revenue and Earnings Growth
Positive
Nov 17, 2025

ReposiTrak reported a 10% increase in revenue to $6.0 million for the first fiscal quarter ending September 30, 2025, with a 13% rise in earnings per share. The company maintained a strong financial position with $29 million in cash and no debt, while also increasing its quarterly dividend by 10%. The company’s focus on automation and operational efficiency is expected to support smaller market participants and enhance profitability, strengthening its competitive position in the traceability and compliance market.

The most recent analyst rating on (TRAK) stock is a Buy with a $16.50 price target. To see the full list of analyst forecasts on ReposiTrak stock, see the TRAK Stock Forecast page.

ReposiTrak Earnings Call Highlights Growth and Strategy
Nov 15, 2025

The recent earnings call from ReposiTrak painted a generally positive picture of the company’s financial health and future prospects. The management expressed optimism due to significant revenue growth, increased profitability, and strong cash management. However, they also acknowledged challenges such as reduced cash from operations, increased operating expenses, higher taxes, and data integrity issues. Despite these hurdles, the company’s strategic initiatives and market positioning suggest a promising future.

ReposiTrak Reports Strong Q1 Fiscal 2026 Results
Nov 14, 2025

ReposiTrak, a leader in food traceability and regulatory compliance, offers cloud-based solutions for retailers, suppliers, and wholesalers to enhance operational controls and ensure regulatory compliance. The company recently reported a robust financial performance for the first fiscal quarter of 2026, with a 10% increase in revenue to $6.0 million and a 13% rise in earnings per share. ReposiTrak’s financial highlights include a 28% increase in operating income and a 9% rise in net income, ending the quarter with $29 million in cash and no debt. The company also declared a quarterly dividend, marking the third consecutive 10% increase since its inception.

Repositrak’s Earnings Call Highlights Robust Growth
Oct 10, 2025

Repositrak’s recent earnings call painted a picture of robust financial health, underscored by impressive revenue and profitability growth. The company demonstrated effective cash management and delivered positive returns to shareholders. However, the call also highlighted concerns about rising operating expenses and the potential impact of tariffs on future performance.

Business Operations and StrategyDividendsFinancial Disclosures
ReposiTrak Reports Strong Financial Year-End Results
Positive
Sep 30, 2025

ReposiTrak reported a successful fiscal year ending June 30, 2025, with an 11% increase in full-year revenue to $22.6 million and a 17% rise in net income to $7.0 million. The company has shifted its strategy to a supplier-centric model, enhancing engagement with individual suppliers and expanding cross-selling opportunities, which has contributed to its revenue growth and improved financial metrics, such as a 24% increase in operating income. ReposiTrak ended the year with $28.6 million in cash and no debt, and announced a 10% increase in its quarterly dividend, reflecting strong financial health and a commitment to returning capital to shareholders.

The most recent analyst rating on (TRAK) stock is a Buy with a $18.50 price target. To see the full list of analyst forecasts on ReposiTrak stock, see the TRAK Stock Forecast page.

ReposiTrak Reports Strong Financial Growth in 2025
Sep 30, 2025

ReposiTrak, a leader in food traceability and regulatory compliance solutions, offers a comprehensive suite of cloud-based applications for retailers, suppliers, and wholesalers to enhance operational controls and ensure compliance. The company recently reported a robust financial performance for the fiscal year ending June 30, 2025, with significant increases in revenue and net income.

Dividends
ReposiTrak Announces Quarterly Dividend Increase
Positive
Sep 19, 2025

On September 19, 2025, ReposiTrak, Inc. announced a quarterly cash dividend of $0.02 per share, payable on November 14, 2025, to shareholders of record as of September 30, 2025. This marks the third increase in the company’s dividend since its establishment, reflecting ReposiTrak’s ongoing commitment to returning value to its shareholders.

The most recent analyst rating on (TRAK) stock is a Buy with a $18.50 price target. To see the full list of analyst forecasts on ReposiTrak stock, see the TRAK Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 21, 2025